Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
9.35
+0.26 (2.86%)
Dec 5, 2025, 4:00 PM EST - Market closed
Lexeo Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 41 | 35.01 | 121.47 | 77.34 | 135.86 | 29.37 |
| Short-Term Investments | 81.77 | 86.5 | - | - | - | - |
| Cash & Short-Term Investments | 122.76 | 121.52 | 121.47 | 77.34 | 135.86 | 29.37 |
| Cash Growth | -21.82% | 0.04% | 57.06% | -43.08% | 362.53% | - |
| Prepaid Expenses | 5.03 | 4.6 | 2.83 | 2.34 | 0.13 | - |
| Other Current Assets | - | - | - | 0.37 | 0.7 | 0.03 |
| Total Current Assets | 127.79 | 126.12 | 124.29 | 80.05 | 136.68 | 29.41 |
| Property, Plant & Equipment | 9.41 | 10.56 | 12.26 | 13.78 | 0.17 | - |
| Long-Term Investments | 3.39 | 7.01 | - | - | - | - |
| Other Long-Term Assets | 3.25 | 3.25 | 3.25 | 3.25 | 0 | 0 |
| Total Assets | 143.84 | 146.94 | 139.81 | 97.08 | 136.86 | 29.41 |
| Accounts Payable | 4.66 | 6.42 | 3.79 | 2.68 | 3.06 | 0.04 |
| Accrued Expenses | 9.69 | 12.82 | 10.29 | 8.09 | 3.78 | 0.25 |
| Current Portion of Leases | 2.72 | 2.67 | 2.61 | 2.83 | - | - |
| Current Income Taxes Payable | - | - | - | 0.51 | 0.53 | 0.04 |
| Current Unearned Revenue | - | - | - | - | 0.05 | 0.14 |
| Other Current Liabilities | 0.21 | 0.94 | 0.55 | 0.24 | 0.03 | 0.22 |
| Total Current Liabilities | 17.27 | 22.85 | 17.24 | 14.35 | 7.45 | 0.7 |
| Long-Term Leases | 5.74 | 7.25 | 9.03 | 10.65 | - | - |
| Other Long-Term Liabilities | - | - | - | - | - | 3.01 |
| Total Liabilities | 23.01 | 30.1 | 26.27 | 25 | 7.45 | 3.71 |
| Common Stock | 0.01 | 0 | 0 | - | 0 | 0 |
| Additional Paid-In Capital | 479.97 | 397.13 | 295.37 | 2.49 | 0.57 | 0.01 |
| Retained Earnings | -359.22 | -280.17 | -181.84 | -115.45 | -56.17 | -5.55 |
| Treasury Stock | -0.02 | -0.02 | - | - | - | - |
| Comprehensive Income & Other | 0.09 | -0.1 | - | - | - | - |
| Total Common Equity | 120.83 | 116.84 | 113.54 | -112.95 | -55.6 | -5.54 |
| Shareholders' Equity | 120.83 | 116.84 | 113.54 | 72.08 | 129.41 | 25.7 |
| Total Liabilities & Equity | 143.84 | 146.94 | 139.81 | 97.08 | 136.86 | 29.41 |
| Total Debt | 8.46 | 9.92 | 11.64 | 13.48 | - | - |
| Net Cash (Debt) | 114.31 | 111.59 | 109.83 | 63.85 | 135.86 | 29.37 |
| Net Cash Growth | -22.04% | 1.61% | 72.00% | -53.00% | 362.53% | - |
| Net Cash Per Share | 2.67 | 3.51 | 20.51 | 39.17 | 87.50 | 20.38 |
| Filing Date Shares Outstanding | 72.99 | 33.2 | 26.65 | 1.61 | 1.58 | 1.51 |
| Total Common Shares Outstanding | 54.93 | 33.07 | 26.65 | 1.61 | 1.58 | 1.51 |
| Working Capital | 110.52 | 103.28 | 107.06 | 65.7 | 129.24 | 28.71 |
| Book Value Per Share | 2.20 | 3.53 | 4.26 | -70.28 | -35.18 | -3.66 |
| Tangible Book Value | 120.83 | 116.84 | 113.54 | -112.95 | -55.6 | -5.54 |
| Tangible Book Value Per Share | 2.20 | 3.53 | 4.26 | -70.28 | -35.18 | -3.66 |
| Machinery | 1.63 | 1.23 | 0.89 | 0.65 | 0.19 | - |
| Leasehold Improvements | 0.27 | 0.27 | 0.25 | 0.23 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.